PT1254143E - Sistemas de administracao de farmacos a base de lipidos contendo derivados de lipidos degradaveis de fosfolipase a2 e sua utilizacao terapeutica - Google Patents
Sistemas de administracao de farmacos a base de lipidos contendo derivados de lipidos degradaveis de fosfolipase a2 e sua utilizacao terapeuticaInfo
- Publication number
- PT1254143E PT1254143E PT01903609T PT01903609T PT1254143E PT 1254143 E PT1254143 E PT 1254143E PT 01903609 T PT01903609 T PT 01903609T PT 01903609 T PT01903609 T PT 01903609T PT 1254143 E PT1254143 E PT 1254143E
- Authority
- PT
- Portugal
- Prior art keywords
- lipid
- degradable
- based drugs
- drugs containing
- administration systems
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title abstract 4
- 102100037611 Lysophospholipase Human genes 0.000 title abstract 2
- 108010058864 Phospholipases A2 Proteins 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229940088679 drug related substance Drugs 0.000 abstract 2
- 229930186217 Glycolipid Natural products 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000211 | 2000-02-10 | ||
| DKPA200000616 | 2000-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1254143E true PT1254143E (pt) | 2005-02-28 |
Family
ID=26068763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01903609T PT1254143E (pt) | 2000-02-10 | 2001-02-09 | Sistemas de administracao de farmacos a base de lipidos contendo derivados de lipidos degradaveis de fosfolipase a2 e sua utilizacao terapeutica |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1254143B1 (pt) |
| JP (1) | JP2003522193A (pt) |
| AT (1) | ATE277935T1 (pt) |
| AU (1) | AU778659B2 (pt) |
| CA (1) | CA2399821A1 (pt) |
| DE (1) | DE60105977T2 (pt) |
| ES (1) | ES2230268T3 (pt) |
| PT (1) | PT1254143E (pt) |
| WO (1) | WO2001058910A2 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2383259A1 (en) | 2002-04-23 | 2003-10-23 | Celator Technologies Inc. | Synergistic compositions |
| AU2002331480B2 (en) * | 2001-10-03 | 2007-10-25 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US7850990B2 (en) | 2001-10-03 | 2010-12-14 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US20080014253A1 (en) * | 2004-11-03 | 2008-01-17 | Kent Jorgensen | Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof |
| WO2006086992A2 (en) * | 2005-02-18 | 2006-08-24 | Liplasome Pharma A/S | Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands |
| WO2007041206A2 (en) | 2005-09-30 | 2007-04-12 | Auburn University | Drug delivery nanocarriers targeted by landscape phage |
| EP2004236A2 (en) * | 2006-03-23 | 2008-12-24 | Liplasome Pharma A/S | Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| EP2123258A1 (en) * | 2008-05-23 | 2009-11-25 | Liplasome Pharma A/S | Liposomes for drug delivery |
| DK177532B1 (en) * | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
| DK177529B1 (en) * | 2009-10-23 | 2013-09-08 | Bio Bedst Aps | Liposomes with improved storage stability |
| EP2343310A1 (en) | 2010-01-08 | 2011-07-13 | Novozymes A/S | Serine hydrolase formulation |
| WO2011098578A2 (en) | 2010-02-12 | 2011-08-18 | Bioneer A/S | Liposome system for ocular administration |
| CZ308596B6 (cs) * | 2017-04-03 | 2020-12-23 | Ústav molekulární genetiky AV ČR, v. v. i. | Deriváty fosfolipidů a jejich použití jako léčiva |
| EP3530266A1 (en) | 2018-02-27 | 2019-08-28 | LipoCoat B.V. | A lipid-based coating composition, and an object having a lipid-based coating |
| EP3530265A1 (en) | 2018-02-27 | 2019-08-28 | LipoCoat B.V. | Universal method for the preparation of lipid-based coatings |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4622392A (en) * | 1984-06-21 | 1986-11-11 | Health Research Inc. (Roswell Park Division) | Thiophospholipid conjugates of antitumor agents |
| US5153000A (en) * | 1988-11-22 | 1992-10-06 | Kao Corporation | Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
| JPH07126166A (ja) * | 1993-10-29 | 1995-05-16 | Sagami Chem Res Center | ホスホリパ−ゼａ２阻害剤 |
| JP3498336B2 (ja) * | 1993-12-06 | 2004-02-16 | 日本油脂株式会社 | リン脂質誘導体 |
| JP3620059B2 (ja) * | 1994-03-04 | 2005-02-16 | 日本油脂株式会社 | 反応性小胞体、形成剤および機能性物質固定化小胞体 |
| DE4408011C1 (de) * | 1994-03-10 | 1995-11-02 | Max Delbrueck Centrum | Pharmazeutisches Mittel zur Tumortherapie |
| US5817856A (en) * | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
| JP3778528B2 (ja) * | 1996-11-08 | 2006-05-24 | 三菱化学株式会社 | ミセルに組み込まれた水溶性高分子物質の分析方法 |
| US5827836A (en) * | 1996-11-15 | 1998-10-27 | Clarion Pharmaceuticals Inc. | Retinoid glycerol phospholipid conjugates |
| US6200598B1 (en) * | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
-
2001
- 2001-02-09 CA CA002399821A patent/CA2399821A1/en not_active Abandoned
- 2001-02-09 ES ES01903609T patent/ES2230268T3/es not_active Expired - Lifetime
- 2001-02-09 PT PT01903609T patent/PT1254143E/pt unknown
- 2001-02-09 WO PCT/DK2001/000092 patent/WO2001058910A2/en active IP Right Grant
- 2001-02-09 AT AT01903609T patent/ATE277935T1/de not_active IP Right Cessation
- 2001-02-09 AU AU31533/01A patent/AU778659B2/en not_active Ceased
- 2001-02-09 JP JP2001558059A patent/JP2003522193A/ja active Pending
- 2001-02-09 EP EP01903609A patent/EP1254143B1/en not_active Expired - Lifetime
- 2001-02-09 DE DE60105977T patent/DE60105977T2/de not_active Expired - Lifetime
- 2001-02-09 EP EP04015791A patent/EP1484332A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1484332A2 (en) | 2004-12-08 |
| AU778659B2 (en) | 2004-12-16 |
| CA2399821A1 (en) | 2001-08-16 |
| EP1484332A3 (en) | 2009-01-21 |
| WO2001058910A3 (en) | 2002-02-21 |
| DE60105977T2 (de) | 2006-02-23 |
| AU3153301A (en) | 2001-08-20 |
| EP1254143A2 (en) | 2002-11-06 |
| DE60105977D1 (de) | 2004-11-04 |
| JP2003522193A (ja) | 2003-07-22 |
| ATE277935T1 (de) | 2004-10-15 |
| ES2230268T3 (es) | 2005-05-01 |
| WO2001058910A2 (en) | 2001-08-16 |
| EP1254143B1 (en) | 2004-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1254143E (pt) | Sistemas de administracao de farmacos a base de lipidos contendo derivados de lipidos degradaveis de fosfolipase a2 e sua utilizacao terapeutica | |
| AR025444A1 (es) | Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos | |
| BR9405798A (pt) | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos | |
| MX9305566A (es) | Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
| DK1165570T3 (da) | Nye phosphorholdige prodrugs | |
| ATE223232T1 (de) | Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen | |
| AR016001A1 (es) | Uso de polimeros de amina alifatica para la fabricacion de medicamentos para la reduccion de niveles de oxalato en un paciente | |
| EA200100298A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5 | |
| CY1110261T1 (el) | Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα | |
| ATE433989T1 (de) | Pharmazeutisch wirksame uridinester | |
| EP0812209A4 (en) | COCHLEAT PHOSPHOLIPID FOR DRUG DELIVERY | |
| ATE453380T1 (de) | Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen | |
| DE60123529D1 (de) | Buprenorphin hydrochlorid enthaltende pflaster | |
| HRP20010684B1 (hr) | Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina | |
| DE60117247D1 (de) | Phosphoramidat-prodrugs | |
| TR199801082T2 (xx) | Fosfonokarbiksilik asitlerin yeni fosfolipid t�revleri, bunlar�n �retimi, bunun yan�s�ra bunlar�n antiviral farmas�tik maddeler olarak kullan�m�. | |
| BR0214159A (pt) | Sistema farmacêutico radiopaco de liberação prolongada | |
| DE50013950D1 (de) | Arzneistoffträger zur kontrollierten wirkstoffapplikation hergestellt aus lipidmatrix-arzneistoff-konjugaten (lak-partikel) | |
| NO975140D0 (no) | Transdermalt terapeutisk system (TTS) for administrasjon av testosteron | |
| DE602005012155D1 (de) | Arzneimittelabgabesysteme auf lipidbasis mit unnatürlichen phospholipase-a2-abbaubaren lipid-derivaten und ihre therapeutische verwendung | |
| ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. | |
| BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
| BRPI0407818A (pt) | sistema de distribuição subcutánea, processo para a preparação do mesmo e uso do mesmo para o tratamento das doenças da deficiência colinérgica | |
| ES2106025T3 (es) | Analogos de gangliosidos semisinteticos. | |
| BR0011135A (pt) | Sistema de ministração terapêutica transdérmica, processo para ministrar um neuroléptico altamente potente a um indivìduo,e uso de um sistema de ministração terapêutica transdérmica |